Skip to main content
Fig. 4 | Journal of Neuroinflammation

Fig. 4

From: New therapeutic targeting of Alzheimer’s disease with the potential use of proline-rich polypeptide complex to modulate an innate immune response - preliminary study

Fig. 4

Distribution of PBLs’ subpopulations at time T = 0 (PBLs without PRP treatment, control), after 24 h of PBLs culture without PRP treatment (control) and after 24 h of PBLs culture with PRP 120 μg/ml. For ANOVA of changes between PBLs T = 24 h and PBLs+PRP T = 24 h, see Table 4

Back to article page

Journal of Neuroinflammation

ISSN: 1742-2094